STING1 and neoplasm: Recently, Gulla et al. showed reduction of tumor growth after treatment with bortezomib and intratumoral administration of synthetic cyclic dinucleotide STING agonist ADU-S100 in 5TGM1 xenograft model in C57BL/KaLwRij mice [13].